• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/10

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

10 Cards in this Set

  • Front
  • Back
Class
Antidysrhythmic
Mechanism of Action
Slows conduction through the AV node; can interrupt re-entrant pathways; slows heart rate by acting directly on the sinus pacemaker cells by slowing impulse formation. The drug of choice for re-entry SVT. Can be used diagnostically for stable, wide complex tachycardia of unknown origin after 2 doses of lidocaine
Indications
Conversion of PSVT to sinus rhythm. May convert re-entry SVT due to Wolff-Parkinson-White syndrome. Not effective in converting a-fib/flutter or V-tach. Most forms of stable narrow-complex SVT.
Contraindications
2nd or 3rd degree AV block (if no pacemaker present), sick sinus syndrome (if no pacemaker present), bronchoconstrictive or bronchospastic lung disease (asthma, COPD), poison or drug induced tachycardia
Adverse reactions/ side effects
generally short duration and mild headache, dizziness, dyspnea, bronchospams, dysrhthmias, palpitation, hypotension, chest pain, facial flushing, cardiac arrest, nausea, metallic taste, pain in the head or neck, paresthesia, diaphoresis
Drug Interactions
Methlxanthines, antagonize the effects of adenosine. Dipyridamole potentiates the effect of adenosine. Cabamazepine (tegretol) may potentiate the AV node blocking effect of adenosine.
How supplied
3 mg/mL in 2-mL and 5 mL flip flop vials
Dosage and Admin
Adult: 6 mg rapid IV bolus over 1-3 seconds, followed by a 20 ml saline flush and elevate extremity. If no response after 1-2 minutes, administer second dose of 12 mg rapid Iv bolus over 1-3 seconds.

Pedi-initial dose .1mg/kg rapid IV/IO push, followed by a 5-10 ml saline flush. Second dose .2 mg/kg rapid IV/IO push followed by 5-10 ml saline flush
Duration of action
Onset:seconds
Peak effect: Seconds
Duration: 12 seconds
Special Considerations
Pregnancy safety: Cat. C. May cause bronchconstriction in asthma pt. Evaluate elderly for signs of dehydration requiring fluid replacement prior to administering adenosine. Short half life limits side effects in most pt.